149 related articles for article (PubMed ID: 16455633)
1. Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct.
Padmanabhan P; Otero J; Ray P; Paulmurugan R; Hoffman AR; Gambhir SS; Biswal S; Ulaner GA
J Nucl Med; 2006 Feb; 47(2):270-7. PubMed ID: 16455633
[TBL] [Abstract][Full Text] [Related]
2. MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter.
Yang Y; Gong MF; Yang H; Zhang S; Wang GX; Su TS; Wen L; Zhang D
Eur Radiol; 2016 Nov; 26(11):4089-4097. PubMed ID: 26960542
[TBL] [Abstract][Full Text] [Related]
3. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
4. Establishing cell-based reporter systems for the analysis of hTERT expression.
Huang YY; Shih JW; Lin JJ
Methods Mol Biol; 2007; 405():87-96. PubMed ID: 18369819
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
6. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
8. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
[TBL] [Abstract][Full Text] [Related]
10. [Construction of an expression vector under the control of hTERT promoter].
Han MK; Zhang HZ; Cheng SY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):384-6. PubMed ID: 15862165
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive monitoring of target gene expression by imaging reporter gene expression in living animals using improved bicistronic vectors.
Wang Y; Iyer M; Annala AJ; Chappell S; Mauro V; Gambhir SS
J Nucl Med; 2005 Apr; 46(4):667-74. PubMed ID: 15809490
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive and real-time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter.
Yu ST; Li C; Lü MH; Liang GP; Li N; Tang XD; Wu YY; Shi CM; Chen L; Li CZ; Cao YL; Fang DC; Yang SM
Cancer; 2012 Apr; 118(7):1884-93. PubMed ID: 22009660
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
15. Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
Takeuchi H; Kanzawa T; Kondo Y; Komata T; Hirohata S; Kyo S; Kondo S
Int J Oncol; 2004 Jul; 25(1):57-63. PubMed ID: 15201989
[TBL] [Abstract][Full Text] [Related]
16. MR molecular imaging of tumors based on an optimal hTERT promoter tyrosinase expression system.
Li C; Hu CJ; Tang B; Yong X; Luo G; Wu YY; Wang SM; Yu ST; Yang SM
Oncotarget; 2016 Jul; 7(27):42474-42484. PubMed ID: 27283901
[TBL] [Abstract][Full Text] [Related]
17. Suppression of colorectal tumor growth by regulated survivin targeting.
Li B; Fan J; Liu X; Qi R; Bo L; Gu J; Qian C; Liu X
J Mol Med (Berl); 2006 Dec; 84(12):1077-86. PubMed ID: 17077982
[TBL] [Abstract][Full Text] [Related]
18. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
19. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
[TBL] [Abstract][Full Text] [Related]
20. [Construction of tumor cell-specific expression vector modulated by human telomerase reserse transcription gene core promoter].
Li HM; Song TB; Yu YC; Huang HY; Zhang M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):96-8, 102. PubMed ID: 16388756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
